In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex

Journal of Clinical Virology

Volumn 41, Issue 2, 2008, Pages 122-128

  Kim, Hye Young ^a   Shin, Hyun Soo ^a   Park, Hyun ^b   Kim, Youn Chul ^b   Yun, Yong Gab ^b   Park, Sun ^a   Shin, Ho Joon ^a   Kim, Kyongmin ^a,b  

^a Ajou University School of Medicine   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

Antiviral; Coronavirus replication; Medicinal herbal extracts

Indexed keywords

CIMICIFUGA RHIZOMA EXTRACT; COPTIS RHIZOME; HERBACEOUS AGENT; MELIAE CORTEX EXTRACT; PAEONIA SUFFRUTICOSA EXTRACT; PHELLODENDRON CORTEX EXTRACT; SOPHORA SUBPROSTRATA RADIX EXTRACT; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CIMICIFUGA; CIMICIFUGA RHIZOMA; CONTROLLED STUDY; CORK TREE; CORONAVIRUS; NONHUMAN; PAEONIA SUFFRUTICOSA; PORCINE EPIDEMIC DIARRHEA VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEVERE ACUTE RESPIRATORY SYNDROME; SOPHORA; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; CIMICIFUGA; HUMANS; MURINE HEPATITIS VIRUS; PHELLODENDRON; PLANT EXTRACTS; PLANTS, MEDICINAL; VERO CELLS; VIRUS REPLICATION;

EID: 38749113891     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.10.011     Document Type: Article

References (26)

1. Balzarini J., Keyaerts E., Vijgen L., Vandermeer F., Stevens M., De Clercq E., et al. Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture. J Antimicrob Chemother 57 (2006) 472-481
2. Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., and Doerr H.W. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361 (2003) 2045-2046
3. Cinatl Jr. J., Michaelis M., Hoever G., Preiser W., and Doerr H.W. Development of antiviral therapy for severe acute respiratory syndrome. Antiviral Res 66 (2005) 81-97
4. Enk R., Ehehalt R., Graham J.E., Bierhaus A., Remppis A., and Greten H.J. Differential effect of Rhizoma coptidis and its main alkaloid compound berberine on TNF-alpha induced NFkappaB translocation in human keratinocytes. J Ethnopharmacol 109 (2007) 170-175
5. Fosmire J.A., Hwang K., and Makino S. Identification and characterization of a coronavirus packaging signal. J Virol 66 (1992) 3522-3530
6. Groneberg D.A., Poutanen S.M., Low D.E., Lode H., Welte T., and Zabel P. Treatment and vaccines for severe acute respiratory syndrome. Lancet Infect Dis 5 (2005) 147-155
7. Haagmans B.L., and Osterhaus A.D. Coronaviruses and their therapy. Antiviral Res 71 (2006) 397-403
8. Hirano N., Fujiwara K., Hino S., and Matumoto M. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch Gesamte Virusforsch 44 (1974) 298-302
9. Hofmann M., and Wyler R. Propagation of the virus of porcine epidemic diarrhea in cell culture. J Clin Microbiol 26 (1988) 2235-2239
10. Kajimoto S., Takanashi N., Kajimoto T., Xu M., Cao J., Masuda Y., et al. Sophoranone, extracted from a traditional Chinese medicine Shan Dou Gen, induces apoptosis in human leukemia U937 cells via formation of reactive oxygen species and opening of mitochondrial permeability transition pores. Int J Cancer 99 (2002) 879-890
11. Keyaerts E., Vijgen L., Maes P., Neyts J., and Van Ranst M. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun 323 (2004) 264-268
12. Kweon C.H., Kwon B.J., Lee J.G., Kwon G.O., and Kang Y.B. Derivation of attenuated porcine epidemic diarrhea virus (PEDV) as vaccine candidate. Vaccine 17 (1999) 1553-2546
13. Lai M.M.C., Brayton P.R., Armen R.C., Patton C.D., Pugh C., and Stohlman S.A. Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J Virol 39 (1981) 823-834
14. Lee H.J., Shieh C.K., Gorbalenya A.E., Koonin E.V., La Monica N., Tuler J., et al. The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology 180 (1991) 567-582
15. Lee JH, Ko NY, Kim NW, Mun SH, Kim JW, Her E, et al. Meliae cortex extract exhibits anti-allergic activity through the inhibition of Syk kinase in mast cells. Toxicol Appl Pharmacol 2007 [Epub ahead of print].
16. Leibowitz J.L., Wilhelmsen K.C., and Bond C.W. The virus-specific intracellular RNA species of two murine coronaviruses: MHV-A59 and MHV-JHM. Virology 114 (1981) 39-51
17. 1H NMR and its application for quality control of commercial traditional Chinese medicine prescriptions. J Pharm Biomed Anal 40 (2006) 173-178
18. Makino S., Taguchi F., Hirano N., and Fujiwara K. Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology 139 (1984) 138-151
19. Makino S., Joo M., and Makino J.K. A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J Virol 65 (1991) 6031-6041
20. Pensaert M.B., and Debouck P. A new coconavirus-like agent associated with diarrhea in swine. Arch Virol 58 (1978) 243-247
21. Raaben M., Einerhand A.W., Taminiau L.J., van Houdt M., Bouma J., Raatgeep R.H., et al. Cyclooxygenase activity is important for efficient replication of mouse hepatitis virus at an early stage of infection. Virol J 4 (2007) 55
22. Sakai S., Kawamata H., Kogure T., Mantani N., Terasawa K., Umatake M., et al. Inhibitory effect of ferulic acid and isoferulic acid on the production of macrophage inflammatory protein-2 in response to respiratory syncytial virus infection in RAW264 7 cells. Mediators Inflamm 8 (1999) 173-175
23. Stockman L.J., Bellamy R., and Garner P. SARS: systematic review of treatment effects. PLoS Med 3 (2006) 1525-1531
24. Tanner J.A., Zheng B.J., Zhou J., Watt R.M., Jiang J.Q., Wong K.L., et al. The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus. Chem Biol 12 (2005) 303-311
25. Weiss S.R., and Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev 69 (2005) 635-664
26. Wu C.Y., Jan J.T., Ma S.H., Kuo C.J., Juan H.F., Cheng Y.S., et al. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci USA 101 (2004) 10012-10017